Daiichi Life Group Q1 Ordinary Profit Nearly Triples as Investment Income Jumps 68%

A quarter made by markets

Daiichi Life Group, Inc. (TSE: 8750) published consolidated results for the three months to June 30, 2026 on August 7, 2026 under Japanese GAAP. Ordinary income rose ¥584.7 billion, or 25.3%, to ¥2,893,002 million, reversing a 22.9% decline a year earlier. Ordinary profit rose ¥166.1 billion to ¥251,057 million (+195.6%) and net profit attributable to owners of the parent ¥125.8 billion to ¥160,065 million (+367.8%).

The market backdrop explains most of it. The Bank of Japan raised its policy rate to 1.0% in June, and long-term yields rose further on caution over crude-driven inflation. Equities climbed worldwide in June as the Middle East moved toward a ceasefire and expectations for AI and semiconductor companies strengthened. For a life insurer holding ¥57.3 trillion of securities, that combination moves the income statement far more than anything in the underwriting book.

Where the ¥584.7 billion of extra income came from

Premium and other income reached ¥1,760.7 billion (+10.9%), investment income ¥1,001.3 billion (+68.3%) and other ordinary income ¥130.8 billion (+4.1%). The company attributes the increase chiefly to higher investment income at Dai-ichi Life Insurance Company. Investment income alone contributed roughly ¥406 billion of the ¥584.7 billion increase — about seven-tenths of it.

Ordinary expenses rose ¥418.5 billion, or 18.8%, to ¥2,641.9 billion. Benefits and claims paid rose 29.9% to ¥1,815.5 billion, investment expenses 35.4% to ¥341.4 billion and operating expenses 13.8% to ¥274.7 billion, while the provision for policy reserves fell 54.1% to ¥110.5 billion. Because ordinary income grew faster than ordinary expenses in absolute terms — ¥584.7 billion against ¥418.5 billion — the difference dropped through to ordinary profit.

Balance sheet

Total assets rose 2.9% to ¥76,322.7 billion. Securities, the dominant holding, rose 3.2% to ¥57,332.9 billion; loans were essentially flat at ¥4,999.5 billion; tangible fixed assets slipped 0.7% to ¥1,230.9 billion and reinsurance receivables 1.3% to ¥2,035.4 billion.

Total liabilities rose 2.6% to ¥71,749.6 billion, of which policy reserves and other insurance liabilities — the great bulk — rose 1.2% to ¥61,972.0 billion. Net assets rose 7.5% to ¥4,573.1 billion, within which net unrealised gains on available-for-sale securities rose 14.8% to ¥1,576.0 billion. That last line is the clearest single indicator of what the quarter's markets did to the balance sheet, and it is also why the equity ratio, at 6.0% against 5.7%, is not a leverage story: a life insurer's assets are policyholder reserves by construction.

Guidance unchanged

Guidance for FY3/2027 is unchanged: ordinary income of ¥10,666,000 million (−5.7%), ordinary profit of ¥869,000 million (+15.3%) and net profit of ¥513,000 million (+17.5%), for earnings per share of ¥142.44 — a figure the company notes is based on the shares outstanding and treasury holdings as at the end of June 2026.

First-quarter ordinary profit of ¥251,057 million is 28.9% of the full-year target and net profit 31.2% — modestly ahead of a level pace, but a single quarter of favourable markets tells you little about the remaining three for a business whose earnings track rates and equity prices this closely. The annual dividend forecast rises sharply, to ¥72.00 per share from ¥54.50, split ¥36.00 interim and ¥36.00 year-end.

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.